Skip to main content
Clinical Trials/ITMCTR2100004654
ITMCTR2100004654
Not yet recruiting
未知

Clinical study on the effectiveness and mechanism of acupuncture combined with donepezil for mild Alzheimer's disease

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Alzheimer's disease
Sponsor
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • This study is designed to include participants aged 50\-80 years with diagnosis of mild AD according to NIA\-AA criteria or with a CDR score between 0\.5 and 1\. The subject included are required to have no history of taking anti\-dementia drugs systematically (donepezil excluded), and at least one reliable caretaker who can accompany the subject during treatment is also needed.

Exclusion Criteria

  • Individuals will be excluded if they have dementia caused by other diseases other than AD, such as cer\-ebrovascular diseases, Creutzfeldt\-Jakob disease and Parkinsons disease; a history of psychological disorders (DSM\-IV criteria); uncorrectable visual or auditory impairment that hampers the completion of related examination. Patients could not participate this study if they are allergic to acupuncture or pace\-maker installed. Pre\-menopausal women will also be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Investigating the clinical efficacy and mechanism of Runfei Huayu recipe in treating connective tissue disease merger interstitial lung disease based on Th17/Treg glycolytic pathway
ITMCTR2200006523Taizhou Hospital of traditional Chinese Medicine
Not yet recruiting
Phase 1
Clinical Efficacy Evaluation and Mechanism Study of Anti-Hepatic Fibrosis Effectively Treated Prescription by Supplementing Deficiency and Clearing Collaterals
ITMCTR2100005161Chengdu University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
A study to investigate belimumab for the treatment of chronic immune thrombocytopeniaChronic Immune ThrombocytopeniaMedDRA version: 15.1Level: LLTClassification code 10051057Term: Idiopathic thrombocytopeniaSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2011-000241-21-DEGlaxoSmithKline Research & Development Limited40
Active, not recruiting
Not Applicable
A study to investigate belimumab for the treatment of chronic immune thrombocytopeniaChronic Immune ThrombocytopeniaMedDRA version: 14.1Level: LLTClassification code 10051057Term: Idiopathic thrombocytopeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2011-000241-21-GBGlaxoSmithKline Research & Development Limited40
Not yet recruiting
Early Phase 1
The research of the clinical effect and mechanism of Zhishen Tiaoxing Tuina therapy on Chronic Fatigue Immune Dysfunction Syndrome
ITMCTR2024000081Affiliated Hospital of Changchun University of Traditional Chinese Medicine